APA (7th ed.) Citation

Villacampa, G., Llop-Guevara, A., Filmann, N., Herencia-Ropero, A., Fasching, P. A., Karn, T., . . . Serra, V. (2025). RAD51 testing in patients with early HER2-negative breast cancer and homologous recombination deficiency: A post hoc analysis of the GeparOLA trial. Clinical cancer research, 31(5), . https://doi.org/10.1158/1078-0432.CCR-24-3148

Chicago Style (17th ed.) Citation

Villacampa, Guillermo, et al. "RAD51 Testing in Patients with Early HER2-negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial." Clinical Cancer Research 31, no. 5 (2025). https://doi.org/10.1158/1078-0432.CCR-24-3148.

MLA (9th ed.) Citation

Villacampa, Guillermo, et al. "RAD51 Testing in Patients with Early HER2-negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial." Clinical Cancer Research, vol. 31, no. 5, 2025, https://doi.org/10.1158/1078-0432.CCR-24-3148.